NL-OMON22012
Completed
Not Applicable
A randomized, multicentre, open label trial comparing the start of the induction of labor with intravenous oxytocin according to the circadian rhythm with standard care.
AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen0 sites400 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Induction of labor with intravenous oxytocin.
- Sponsor
- AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women are eligible to participate when the clinician judges that it is indicated to induce labor and the cervix is favourable for induction with a drip of oxytocin.
Exclusion Criteria
- •Excluded are women with:
- •1\. Intrauterine fetal death;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study) - CYSIFEUCTR2006-005299-42-BEGETAID100
Active, not recruiting
Not Applicable
A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study) - CYSIF- Diagnosis of UC according to Lennard-Jones criteria - Endoscopically demonstrated colorectal lesions localized above the anal margin and extending at least up to 15cm proximally.- Severe acute flare of UC with a Lichtiger Index score > 10.- Refractoriness to high dose intravenous steroid therapy (= 0.8 mg/kg/d of methylprednisolone or equivalent) given for at least 5 days.MedDRA version: 9.1Level: LLTClassification code 10045282Term: UCEUCTR2006-005299-42-FRGETAID100
Active, not recruiting
Not Applicable
A randomized, multicentre, open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitisSatunnaistettu, avoin, vertaileva monikeskustutkimus siklosporiinista ja infliximabista kortikosteroidille reagoimattoman vaikean haavaisen paksusuolitulehduksen hoidossa. - CYSIF STUDYEUCTR2006-005299-42-FIGroupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)100
Suspended
Not Applicable
A comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes characterized by an asymmetric insulin requirement across the day and night.Type 2 diabetes.NL-OMON25809Dr. J.H. de VriesAcademic Medical Center - AmsterdamandProf. Philip HomeUniversity of Newcastle upon Tyne, UK175
Completed
Phase 4
A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe ColitisUlcerative ColitisNCT02425852Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives65